CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $2,743,765
- in 2 filings
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net +$1,035,724. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$2.7M President and CEO 2 filings
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-29 | Powl Brian T. Chief Commercial Officer | Sale | −15,430 | $10.75 | $166K | 136,819 |
| 2026-09-28 | Powl Brian T. Chief Commercial Officer | Sale | −9,020 | $10.50 | $95K | 160,249 |
| 2026-09-28 | Powl Brian T. Chief Commercial Officer | Sale | −8,000 | $10.56 | $84K | 152,249 |
| 2026-08-21 | Powl Brian T. Chief Commercial Officer | Sale 10b5-1 | −4,345 | $11.89 | $52K | 169,269 |
| 2026-05-21 | Powl Brian T. Chief Commercial Officer | Sale 10b5-1 | −10,000 | $11.00 | $110K | 173,614 |
| 2026-05-19 | Powl Brian T. Chief Commercial Officer | Sale 10b5-1 | −339 | $9.21 | $3K | 183,614 |
| 2026-01-27 | Powl Brian T. Chief Commercial Officer | Sale | −4,842 | $8.46 | $41K | 184,847 |
| 2026-01-27 | Powl Brian T. Chief Commercial Officer | Sale | −1,572 | $8.46 | $13K | 183,275 |
| 2026-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award | +50,000 | 189,689 | ||
| 2026-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award · Option to purchase common stock | +100,000 | 100,000 | ||
| 2025-11-14 | Powl Brian T. Chief Commercial Officer | Sale | −8,887 | $11.18 | $99K | 139,689 |
| 2025-11-13 | Powl Brian T. Chief Commercial Officer | Grant or award | +48,900 | 148,576 | ||
| 2025-09-29 | Powl Brian T. Chief Commercial Officer | Sale | −8,891 | $8.94 | $80K | 99,676 |
| 2025-09-27 | Powl Brian T. Chief Commercial Officer | Grant or award | +48,900 | 108,567 | ||
| 2025-01-28 | Powl Brian T. Chief Commercial Officer | Sale | −1,583 | $7.87 | $12K | 59,667 |
| 2025-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award | +46,250 | 61,250 | ||
| 2025-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award · Option to purchase common stock | +92,500 | 92,500 | ||
| 2024-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award | +15,000 | 15,000 | ||
| 2024-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award · Option to purchase common stock | +30,000 | 30,000 | ||
| 2023-08-14 | Powl Brian T. Chief Commercial Officer | Grant or award · Option to purchase common stock | +200,000 | 200,000 |
Page 1 of 1 · 20 trades